San Diego students explore immunology through art
Celebrating the annual LJI Art of the Immune System Student Competition
Virologist Onyeka Chukwudozie wins support for international collaboration
New Merkin Fellowship to support U.K. collaboration on Lassa virus research
Even as SARS-CoV-2 mutates, some human antibodies fight back
A 'cocktail' of human antibodies shows promise in fighting severe SARS-CoV-2 infections
nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator
Severe Asthma: Disease Providing New Insights Into Its Complex Immune Landscape
The immune landscape of the lungs is a complex place. In this scientific seminar, Anuradha Ray, Ph.D., Endowed Chair in
The new machine on the scene
Three LJI Cores join forces to bring new spatial transcriptomics capacity to researchers
We’ve learned a lot from lymphocytic choriomeningitis virus—now the time has come to fight it
LJI scientists share high-resolution view of the lymphocytic choriomeningitis virus (LCMV) glycoprotein together with a neutralizing antibody
Innate immune sensors as potential targets for acute kidney injury
Dianne McKay, M.D., faculty member at Scripps Research and nephrologist with Scripps Clinic and Scripps Green Hospital, shares new research
LJI Professor Alessandro Sette elected to the American Academy of Microbiology
Sette has led investigations into the T cell response to SARS-CoV-2, tuberculosis, and more
Lasting relief may be on the horizon for patients with atopic dermatitis
LJI research collaboration with Kyowa Kirin Co., Ltd., points to a novel approach to treat the most common form of eczema
New $17 million grant establishes LJI as global hub for immunology data curation and analysis
NIAID support opens gateway to new research into human immune responses to viruses, the development of autoimmune diseases, and more
LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved